Ely S W, Matherne G P, Coleman S D, Berne R M
Department of Physiology, University of Virginia Health Sciences Center, Charlottesville 22908.
J Mol Cell Cardiol. 1992 Nov;24(11):1321-32. doi: 10.1016/0022-2828(92)93097-4.
We employed an isolated guinea-pig heart model perfused at constant pressure (70 cmH2O) to test the hypothesis that inhibition of adenosine metabolism increases interstitial adenosine concentrations (as measured with epicardial discs) and coronary flow. Iodotubercidin (ITU, 1 microM) and EHNA (erythro-9-[2-hydroxy-3-nonyl] adenine, 5 microM) were used to inhibit adenosine kinase and deaminase, respectively during control conditions and during metabolic stimulation with 1 microM isoproterenol. The adenosine receptor blocker 8-phenyltheophylline (8-PT) was used during control conditions to assess whether the response seen was adenosine specific. ITU plus EHNA decreased heart rate (202 +/- 10 to 136 +/- 11 beats/min) and increased coronary flow (8.2 +/- 0.3 to 12.4 +/- 0.9 ml/min/g) without a change in MVO2, developed pressure or dP/dt. ITU plus EHNA increased adenosine concentrations in epicardial fluid (0.24 +/- 0.07 microM to 1.02 +/- 0.09 microM) and venous effluent (40 +/- 3 nM to 262 +/- 32 nM) during control conditions, and adenosine release increased from 389 +/- 96 pmols/min/g to 3480 +/- 365 pmols/min/g. 8-PT infusion reversed the effects on heart rate and coronary flow and resulted in a persistent elevation of epicardial fluid adenosine concentrations. During metabolic stimulation with 1 microM isoproterenol, ITU plus EHNA significantly limited the increase in heart rate and ventricular developed pressure and dP/dt while coronary flow increased to a significantly greater extent. Myocardial oxygen consumption was similar during metabolic stimulation between the two groups (vehicle vs. ITU plus EHNA). Epicardial fluid adenosine concentration in the vehicle-treated group increased from 0.17 +/- 0.3 microM to 0.34 +/- 0.02 microM at 15 min of isoproterenol stimulation whereas it increased from 1.10 +/- 0.02 microM to 2.90 +/- 0.46 microM in the ITU plus EHNA-treated group. Inhibition of adenosine metabolism during metabolic stimulation significantly increased venous adenosine concentrations and adenosine release and reduced inosine and hypoxanthine release proportionately. The release of adenosine+inosine+hypoxanthine was unchanged. Inhibition of adenosine metabolism provides evidence supporting the hypothesis that adenosine plays a role in regulating coronary vascular resistance as well as influencing heart rate and ventricular inotropy.
我们采用恒压(70 cmH₂O)灌注的离体豚鼠心脏模型,以检验腺苷代谢抑制增加间质腺苷浓度(用心外膜圆盘测量)和冠脉流量这一假说。在对照条件下以及用1 μM异丙肾上腺素进行代谢刺激期间,分别使用碘结核菌素(ITU,1 μM)和EHNA(赤型-9-[2-羟基-3-壬基]腺嘌呤,5 μM)抑制腺苷激酶和脱氨酶。在对照条件下使用腺苷受体阻滞剂8-苯基茶碱(8-PT),以评估所观察到的反应是否具有腺苷特异性。ITU加EHNA可降低心率(从202±10降至136±11次/分钟)并增加冠脉流量(从8.2±0.3增至12.4±0.9 ml/分钟/克),而MVO₂、舒张末压或dP/dt无变化。在对照条件下,ITU加EHNA可增加心外膜液中的腺苷浓度(从0.24±0.07 μM增至1.02±0.09 μM)和静脉流出液中的腺苷浓度(从40±3 nM增至262±32 nM),腺苷释放量从389±96 pmol/分钟/克增至3480±365 pmol/分钟/克。输注8-PT可逆转对心率和冠脉流量的影响,并导致心外膜液腺苷浓度持续升高。在用1 μM异丙肾上腺素进行代谢刺激期间,ITU加EHNA显著限制了心率、心室舒张末压和dP/dt的增加,而冠脉流量增加幅度更大。两组在代谢刺激期间的心肌耗氧量相似(溶剂对照组与ITU加EHNA组)。在异丙肾上腺素刺激15分钟时,溶剂对照组的心外膜液腺苷浓度从0.17±0.03 μM增至0.34±0.02 μM,而ITU加EHNA治疗组则从1.10±0.02 μM增至2.90±0.46 μM。在代谢刺激期间抑制腺苷代谢可显著增加静脉腺苷浓度和腺苷释放,并相应降低肌苷和次黄嘌呤释放。腺苷+肌苷+次黄嘌呤的释放无变化。腺苷代谢抑制提供了证据支持腺苷在调节冠脉血管阻力以及影响心率和心室收缩力中起作用这一假说。